eMedicine Specialties > Pediatrics: General Medicine > Nephrology
Nephritis: Follow-up
Updated: Jul 18, 2008
Follow-up
Further Inpatient Care
- Inpatient care is usually necessary only to manage severe hypertension or complications of acute or chronic renal failure (eg, dialysis access, uremic syndrome, congestive heart failure, electrolyte abnormalities such as hyperkalemia and pericardial effusion). These problems are infrequent in the general pediatric population.
Further Outpatient Care
- Outpatient care is an extension of inpatient care.
- Outpatient care may be as simple as observation in a child with tubulointerstitial nephritis or resolving poststreptococcal glomerulonephritis (GN) or may involve antihypertensives, diuretics, and diet modification as in a child with IgA nephropathy or membranoproliferative GN and preserved renal function.
- Outpatient care may involve dialysis and transplantation in a child who develops end-stage renal disease.
Inpatient & Outpatient Medications
- No specific change in medications is necessary for transition from inpatient to outpatient care.
Transfer
- A physician who has experience in managing renal failure in children should care for children with renal failure. In the United States, this is frequently at a tertiary facility.
Deterrence/Prevention
- No effective methods of deterrence or prevention are known.
Complications
- Primary complications associated with hypertension
- Seizure
- Encephalopathy
- Stroke
- End-organ damage
- Primary complications associated with kidney failure
- Fluid overload
- Electrolyte abnormality
- Uremic symptoms
- Anemia
- Abnormal bone mineralization
- Sexual dysfunction
- Poor growth
- Anorexia
- Endocrine abnormalities
Prognosis
- The overall prognosis for survival in children with all forms of nephritis is good.
Patient Education
- Education about the specific nephritis is helpful.
- Encourage medication compliance and a healthy lifestyle (eg, ideal body weight, no smoking, exercise, avoidance of risk behaviors).
- For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Blood in the Urine.
Miscellaneous
Medicolegal Pitfalls
- Failure to consider the diagnosis in a child with nephritis may delay diagnosis and treatment, which may allow progression to end-stage renal disease and allow complications, such as hypertensive seizures, to occur. A provider might be held responsible.
More on Nephritis |
| Overview: Nephritis |
| Differential Diagnoses & Workup: Nephritis |
| Treatment & Medication: Nephritis |
Follow-up: Nephritis |
| References |
| « Previous Page |
References
Marcus SB, Brown JB, Melin-Aldana H, Strople JA. Tubulointerstitial nephritis: an extraintestinal manifestation of Crohn disease in children. J Pediatr Gastroenterol Nutr. Mar 2008;46(3):338-41. [Medline].
Adler SG, Cohen AH, Glassock RJ. Secondary glomerular diseases. In: Brenner BM, ed. The Kidney. 5th ed. Philadelphia, PA: WB Saunders Co; 1996:1498-1596.
Balow JE, Austin HA. Treatment of proliferative lupus nephritis. Am J Kidney Dis. Feb 2004;43(2):383-5. [Medline].
Bargman JM. Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int Suppl. Jun 1999;70:S3-16. [Medline].
Cattran DC. Evidence-based recommendations for the management of glomerulonephritis. Introduction. Kidney Int Suppl. Jun 1999;70:S1-2. [Medline].
Eddy AA. Mechanisms of immune glomerular injury. In: Barrett TM, Avener EV, Harmon H, eds. Pediatric Nephrology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:641-68.
Eknoyan G. Tubulointerstial nephritis. In: Massry SG, Glassock RJ, eds. Massry and Glassock's Textbook of Nephrology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:746-58.
Flanc RS, Roberts MA, Strippoli GF, et al. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis. Feb 2004;43(2):197-208. [Medline].
Glassock RJ, Cohen AH, Adler SG. Primary glomerular diseases. In: Brenner BM, ed. The Kidney. 5th ed. Philadelphia, PA: WB Saunders Co; 1996:1392-1497.
Goda C, Kotake S, Ichiishi A, et al. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005;140(4):637-41. [Medline].
Gonzalez B, Hernandez P, Olguin H, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus. 2005;14(11):918-23. [Medline].
Lee JW, Kim HJ, Sung SH, Lee SJ. A case of tubulointerstitial nephritis and uveitis syndrome with severe immunologic dysregulation. Pediatr Nephrol. 2005;20(12):1805-8. [Medline].
Further Reading
Keywords
nephritis, glomerulonephritis, GN, Bright disease, interstitial nephritis, tubulointerstitial disease, tubulointerstitial nephritis, TIN, hypertension, hematuria, edema, systemic lupus erythematosus, SLE, membranoproliferative glomerulonephritis, membranoproliferative GN, mesangial proliferative GN, Henoch-Schönlein purpura, immunoglobulin A nephropathy, Alport syndrome, vesicoureteral reflux, oxalosis, Crohn disease, cerebral hemorrhage, hyperkalemia, pulmonary edema, heart failure, ascites, encephalopathy, polyuria
Follow-up: Nephritis